The In-Vitro Diagnostic portfolio provides the golden standard of molecular based immunoassay technology for liver surveillance, cutting edge clinical diagnostic chemicals for leading laboratories across the country and diagnostic chemicals for OEM white labeling products. The company is headquartered in Lexington, Massachusetts.

FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, highly functional materials, document solutions and imaging products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2021, the company had global revenues of $21 billion, at an exchange rate of 106 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship.

Fujifilm Healthcare Americas Corporation Downloads

Scenaria View - Model 128 - Premium Performance CT Solution - Brochure

Oasis - Specification

Fujifilm Echelon Oval - Model 1.5T - MR System - Datasheet

Hitachi - Model Echelon Oval 1.5T - Refurbished MRI Systems - Brochure

Hitachi - Model Echelon Oval 1.5T - Refurbished MRI Systems - Brochure

Contact supplier